Our CEO George Ng will be attending BIO International Convention June 3-6. 2024. Please email [email protected] to set up a meeting. #oncology #cancer #chemotherapy
Processa Pharmaceuticals’ Post
More Relevant Posts
-
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population https://lnkd.in/eBwZi9Qd 🧪 #CancerResearch #Pathophysiology #CancerPrevention #CancerDiagnosis #CancerTreatment #Cancer #Oncology
To view or add a comment, sign in
-
-
📜 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐈𝐦𝐦𝐮𝐧𝐨-𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐎𝐮𝐫 𝐖𝐡𝐢𝐭𝐞𝐩𝐚𝐩𝐞𝐫! Unlock the future of cancer treatment with insights from our comprehensive whitepaper. Delve into: 🔬 The science behind immuno-oncology 💡 Cutting-edge therapies and their potential 🚀 Challenges we must overcome 👇 𝑪𝒍𝒊𝒄𝒌 𝒕𝒉𝒆 𝒍𝒊𝒏𝒌 𝒊𝒏 𝒕𝒉𝒆 𝒄𝒐𝒎𝒎𝒆𝒏𝒕𝒔 𝒕𝒐 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒉𝒆 𝒘𝒉𝒊𝒕𝒆𝒑𝒂𝒑𝒆𝒓! #Cancer #Immunotherapy #Biotherapeutics #NBE #LargeMolecules #ImmunoOncology #TherapiesAndChallenges #MedicalAdvancements
To view or add a comment, sign in
-
💬Check out the #Article "LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer" 👏by Xiao Tong et al. Southeast University 🔗Find out more here: https://lnkd.in/dHPqtv_S Keywords: lncRNA HCP5; encoded protein; ferroptosis
To view or add a comment, sign in
-
-
Chemotherapy-induced nausea is common, especially with cisplatin, but it can be managed with preventive care. In this video, learn about anti-nausea medications and tips to reduce discomfort. https://lnkd.in/gG3Di_a2 #nausea #cisplatin #chemotherapy #cancer #oncology #simplecancerexplanations #PRIMR
To view or add a comment, sign in
-
-
Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer https://lnkd.in/exeZMiAN 🧪 #CancerResearch #Pathophysiology #CancerPrevention #CancerDiagnosis #CancerTreatment #Cancer #Oncology
To view or add a comment, sign in
-
-
Sharing recent insights on the impact of Alectinib in adjuvant therapy for non-small cell lung cancer (NSCLC). Thanks OncoDaily for open this space. #LungCancer #Alectinib #MedicalInnovation
Wu Y-L et al. have just released the results of a preplanned interim analysis from the ALINA trial - Sergio Cifuentes Canaval https://lnkd.in/ggb3PGyX #oncodaily #oncology #cancer #NSCLC #ALKpositive #ALINAtrial #alectinib #chemotherapy #clinicaltrial #respiratoryoncology
To view or add a comment, sign in
-
American Society of Clinical Oncology (ASCO) 24 Updates: Exploring the Role of ACP1: Molecular Insights and Clinical Impact Nour Abdallah Cleveland Clinic https://lnkd.in/dQjNP6SV #ASCO24 #ASCO #Cancer #ProstateCancer #OncoDaily #OncoDaily
To view or add a comment, sign in
-
-
Comprehensive hematologic molecular profiling with cfDNA and cfRNA detects and differentiates driver and sub-clonal mutations, determines prognosis, and identifies targeted therapies for personalized medicine. #NGS #cancer #cancerdetection https://hubs.la/Q02qs7rn0
To view or add a comment, sign in
-
-
🔊 Latest article! 💡 Pioneering the advancement of pre-targeted radioimmunotherapies Although pre-targeting is still in its infancy, it has immense potential to increase state-of-the-art radioligand therapies. In this Q&A, Francesco Sergi-Lindell, CEO of PreTT, reveals how their pre-targeted RLTs surpass traditional methods, transforming cancer treatment. Click the link in the comments to read more! 👇 #cancer #radioligand #therapeutics
To view or add a comment, sign in
-
-
The Multiple Myeloma Research Consortium® is a collaborative network of leading #myeloma treatment centers that conduct early-stage clinical trials to evaluate novel treatment strategies for patients. Given their size and complexity. these studies cannot be done by any single institution The focus is on advancing innovative treatment approaches in areas of unmet clinical need, including relapsed/refractory, high-risk newly diagnosed, and high-risk smoldering #myeloma. #cancer #cancerdetection https://hubs.la/Q02phymJ0
New Multiple Myeloma Treatments & Clinical Trials | The MMRF
To view or add a comment, sign in
More from this author
-
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Processa Pharmaceuticals 2y -
Processa Pharmaceuticals Announces Launch of Website to Increase Awareness of Ulcerative Necrobiosis Lipoidica
Processa Pharmaceuticals 2y -
The Benefits of a Regulatory Science Approach for the Development of Drugs
Processa Pharmaceuticals 2y